vainas hct 10mg/160mg/12,5mg potahovaná tableta
belupo lijekovi i kozmetika, d.d., koprivnica chorvatsko - 12990 amlodipin-besilÁt; 13182 valsartan; 728 hydrochlorothiazid - potahovaná tableta - 10mg/160mg/12,5mg - valsartan, amlodipin a hydrochlorothiazid
vainas hct 10mg/320mg/25mg potahovaná tableta
belupo lijekovi i kozmetika, d.d., koprivnica chorvatsko - 12990 amlodipin-besilÁt; 13182 valsartan; 728 hydrochlorothiazid - potahovaná tableta - 10mg/320mg/25mg - valsartan, amlodipin a hydrochlorothiazid
vainas hct 5mg/160mg/12,5mg potahovaná tableta
belupo lijekovi i kozmetika, d.d., koprivnica chorvatsko - 12990 amlodipin-besilÁt; 13182 valsartan; 728 hydrochlorothiazid - potahovaná tableta - 5mg/160mg/12,5mg - valsartan, amlodipin a hydrochlorothiazid
vainas hct 5mg/160mg/25mg potahovaná tableta
belupo lijekovi i kozmetika, d.d., koprivnica chorvatsko - 12990 amlodipin-besilÁt; 13182 valsartan; 728 hydrochlorothiazid - potahovaná tableta - 5mg/160mg/25mg - valsartan, amlodipin a hydrochlorothiazid
valsacor 80mg potahovaná tableta
krka, d.d., novo mesto, novo mesto array - 13182 valsartan - potahovaná tableta - 80mg - valsartan
valzap combi 160mg/12,5mg potahovaná tableta
zentiva, k.s., praha array - 13182 valsartan; 728 hydrochlorothiazid - potahovaná tableta - 160mg/12,5mg - valsartan a diuretika
valzap combi 160mg/25mg potahovaná tableta
zentiva, k.s., praha array - 13182 valsartan; 728 hydrochlorothiazid - potahovaná tableta - 160mg/25mg - valsartan a diuretika
wamlox 5mg/320mg potahovaná tableta
krka, d.d., novo mesto, novo mesto array - 12990 amlodipin-besilÁt; 13182 valsartan - potahovaná tableta - 5mg/320mg - valsartan a amlodipin
neparvis
novartis europharm limited - sacubitril, valsartan - srdeční selhání - agens působící na systém renin-angiotenzin - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.
entresto
novartis europharm limited - sacubitril, valsartan - srdeční selhání - antagonisté angiotensinu ii, jiné kombinace, látky působící na renin-angiotensinový systém - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.